Back to Drug Index
EGYPTIAN PHARMACEUTICAL DIRECTORY

IRINOTECAN MYLAN 40MG/2ML VIAL

OFFICIAL RETAIL PRICE EGP 551.00
Active Molecule
IRINOTECAN
Form & Route
Injection (Vial / Ampoule)
Manufacturer
MYLAN > ONE PHARMA TECH
Therapeutic Class
ANTINEOPLASTIC
Cost-Saving Equivalent Available: You can save up to EGP 201.00 by switching to IRINOTECAN ACTAVIS 40MG/2ML VIAL(N/A) (EGP 350.00).
Commercial brands in Egypt sharing the exact same active molecule & dosage form.
Injection (Vial / Ampoule) • PFIZER
EGP 2,015.00 +EGP 1,464.00
Injection (Vial / Ampoule) • PFIZER
EGP 4,290.00 +EGP 3,739.00
Injection (Vial / Ampoule) • PFIZER
EGP 846.00 +EGP 295.00
Injection (Vial / Ampoule) • ACTAVIS
EGP 700.00 +EGP 149.00
Injection (Vial / Ampoule) • ACTAVIS
EGP 350.00 Saves EGP 201.00
Injection (Vial / Ampoule) • MYLAN > ONE PHARMA TECH
EGP 1,310.00 +EGP 759.00
Injection (Vial / Ampoule) • FRESENIUS KABI > EGYPTIAN GROUP FOR IMPORT AND EXPORT
EGP 800.00 +EGP 249.00
General Form • FRESENIUS KABI > EGYPTIAN GROUP FOR IMPORT AND EXPORT
EGP 400.00 Saves EGP 151.00
Injection (Vial / Ampoule) • HIKMA SPECIALIZED PHARMACEUTICALS
EGP 1,173.00 +EGP 622.00
Injection (Vial / Ampoule) • HIKMA SPECIALIZED PHARMACEUTICALS
EGP 495.00 Saves EGP 56.00
Verified Directory Notice: Official retail pricing and commercial specifications reflect Egyptian MOH/EDA registered records. Always consult a licensed healthcare professional or pharmacist prior to modifying or substituting prescription drug treatments.

System Notice

Confirm Action